Drug encapsulation

Polymeric particles are extensively studied as particulate carriers in the pharmaceutical and medical fields, because they show promise as drug delivery systems as a result of their controlled- and sustained-release properties.

Related publications

Chitosan nanoparticles loaded with dorzolamide and pramipexole
Chitosan derivatives as effective nanocarriers for ocular release of timolol drug
Formulation and In-Vitro Characterization of Chitosan-Nanoparticles Loaded with the Iron Chelator Deferoxamine Mesylate (DFO)
Paclitaxel Magnetic Core–Shell Nanoparticles Based on Poly(lactic acid) Semitelechelic Novel Block Copolymers for Combined Hyperthermia and Chemotherapy Treatment of Cancer
Use of mesoporous cellular foam (MCF) in preparation of polymeric microspheres for long acting injectable release formulations of paliperidone antipsychotic drug
Design of a Multifunctional Nanoengineered PLLA Surface by Maximizing the Synergies between Biochemical and Surface Design Bactericidal Effects
Differentiation Capacity of Monocyte-Derived Multipotential Cells on Nanocomposite Poly(e-caprolactone)-Based Thin Films

Methods for encapsulation

Findings

Poly(Lactic Acid)-Based Microparticles for Drug Delivery Applications	Dissolution Enhancement and Controlled Release of Paclitaxel Drug via a Hybrid Nanocarrier Based on mPEG-PCL Amphiphilic Copolymer and Fe-BTC Porous Metal-Organic Framework	Illustration of possible distribution patterns of drug the self-assembly PPAd/poly(ε-caprolactone) (PCL) nanoparticles

Drug encapsulation

Methods for encapsulation

Findings

Poly(Lactic Acid)-Based Microparticles for Drug Delivery Applications

Dissolution Enhancement and Controlled Release of Paclitaxel Drug via a Hybrid Nanocarrier Based on mPEG-PCL Amphiphilic Copolymer and Fe-BTC Porous Metal-Organic Framework

Illustration of possible distribution patterns of drug the self-assembly PPAd/poly(ε-caprolactone) (PCL) nanoparticles